Navigation Links
Three Nova Southeastern University researchers receive patents
Date:5/8/2014

FORT LAUDERDALE-DAVIE, Fla. Three Nova Southeastern University's (NSU) professors from three different colleges recently secured patents for their innovations.

"The idea of a university is to further innovation, promote scholarship and ultimately benefit humanity," said NSU President George L. Hanbury II, Ph.D. "Professors Rathinavelu, Thompson, and Harbaugh have developed new solutions to benefit the global community in their respective fields of pharmaceutical research, dentistry, and law, and I am proud to recognize them for their achievements."

Appu Rathinavelu, Ph.D., associate dean for institutional planning and development at NSU's College of Pharmacy, and executive director of NSU's Rumbaugh-Goodwin Institute for Cancer Research, received a Japanese patent for developing a novel cancer treatment. The small organic molecule called "JFD" that he and his team discovered is anti-angiogenic, meaning it "starves" tumors and other cancer cells by preventing blood flow that supplies the tumors with oxygen and nutrients that would otherwise help them to grow and survive. This molecule is less expensive to manufacture, stable in storage, expected to be less toxic, and is more effective against solid tumors. It is specifically designed to battle breast, ovarian, prostate, lung and colorectal cancers.

Jeffrey Thompson, Ph.D., professor of prosthodontics and director of the Biosciences Research Center in NSU's College of Dental Medicine, secured a U.S. patent for developing a surface modification technology to promote chemical bonding between high-performance ceramic materials like alumina and zirconia and biological materials, like tooth structures, and synthetic materials, like dentures and crowns. The research was conducted with a team of researchers from RTI International in Durham, N.C., and funded by a National Institute of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) grant.

Joseph Harbaugh, LL.M., professor of law and dean emeritus at NSU's Shepard Broad Law Center, has received a U.S. patent for developing a computer-based system called AAMPLE, the Alternative Admissions Model Program in Legal Education. The program reviews students' outcomes in a small number of classes to predict their likelihood of excelling in law school and passing the state bar exam. This differs from the widespread practice of heavily weighing students' LSAT scores and GPAs to determine admission to law school. AAMPLE is an alternate method to understand students' abilities to think critically and succeed in law school and as professionals.

"These three patents illustrate NSU's focus on developing novel, useful and relevant products and services to improve people's lives," said Gary S. Margules, Sc.D., NSU vice president for research and technology transfer.


'/>"/>

Contact: Jeremy Katzman, M.B.A.
j.katzman@nova.edu
954-262-5408
Nova Southeastern University
Source:Eurekalert  

Related medicine news :

1. Three Johns Hopkins faculty win Novo Nordisk awards for diabetes research
2. Three-quarters of people with seasonal and pandemic flu have no symptoms
3. Same cell death pathway involved in three forms of blindness, Penn team finds
4. Three Reasons Why Eye Contact Creates Better Sex
5. Foot Levelers to Honor Three at Parker Seminars Las Vegas
6. Natural Algae Astaxanthin Association Formed by Three Leading Astaxanthin Producers
7. Life Insurance No Medical Exam Plans Have Three Important Advantages For Seniors
8. Bioforce Announces Echinaforce® Named One of Three Top Supplements for Cold and Flu
9. MedMar Healing Center Co-founder Rafael Hernandez Goes the Distance for Leukemia and Lymphoma Society, Running Three Marathons for Nonprofit Health Organization
10. Antiperspirant for Hyperhidrosis, SweatBlock, Surpasses "Three Million Sold" Threshold
11. HUMAN Ranks #7 on Los Angeles Business Journal’s “Fastest Growing Private Companies” List with Three-Year Sales Growth of 514%
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Three Nova Southeastern University researchers receive patents
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: